What is Inflammatory Breast Cancer?
This paper was prepared for English 99, 3325 taught by Professor Richardson
Inflammatory breast cancer is rare and spreads aggressively. The 5 year cancer survival rate after doing chemotherapy, surgery and radiation therapy is still really short of between 24 and 49 percent survival rate. For Stage 4, the 5 year survival rate is only 11 percent.
What is Inflammatory Breast Cancer
I choose to write my paper on Inflammatory Breast Cancer because my mother was recently diagnosed with IBC on the end of March 2013. While doing the research for this paper I found out a lot of stuff that I really ...view middle of the document...
A biopsy is where they take a small portion of the affected tissue and some from the area around it to test for cancerous cells. If the results come back positive for invasive carcinoma they will order more test to be done. First they would perform a diagnostic mammogram and ultrasound. Then they would order a PET or CT scan and bone scan to see if any other parts of the body or organs have been affected. There is now genetic testing you can have done to help you know early if you are going to develop breast cancer. The test looks for BRCA1 and BRCA2. Inherited BRCA gene mutations are responsible for about 5 percent of breast cancers. (Mayo Clinic, n.d.)
In order to treat IBC first you go on systemic chemotherapy, followed by surgery to remove the tumor, then radiation therapy. This is referred to as the multimodal approach. Studies have shown that women treated in this manner respond better to the treatment and also have a better survival rate. First you are given around six cycles of neoadjuvant chemotherapy within 4 to 6 months before moving on to the surgery, unless the doctors feel that it spread too fast and you can’t wait for the surgery any longer. That is when they go in and perform a modified radical mastectomy, removal of the breast and any other affected surrounding area. Then you will receive the radiation therapy to make sure that the cells have been killed.
Women who only received one of the three treatments had less than a 5 year survival rate. The survival range being cancer free after receiving the multimodal treatment from 24 to 49 percent. According to the NCI’s surveillance, Epidemiology, and End Results (SEER) program the 5 year survival rate from 1988 to 2001 was 34 percent. ...